My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 625

    1.

    Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.

    Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM.

    Ann Intern Med. 1999 May 18;130(10):800-9.PMID: 10366369 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.

    Quinlan DJ, McQuillan A, Eikelboom JW.

    Ann Intern Med. 2004 Feb 3;140(3):175-83.PMID: 14757615 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

    Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE.

    Ann Intern Med. 2001 Nov 20;135(10):858-69. Review.PMID: 11712876 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

    van Der Heijden JF, Hutten BA, Büller HR, Prins MH.

    Cochrane Database Syst Rev. 2000;(4):CD002001. Review. Update in: Cochrane Database Syst Rev. 2002;(1):CD002001. PMID: 11034739 [PubMed - indexed for MEDLINE]Related articles

    5.

    Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.

    Gould MK, Dembitzer AD, Sanders GD, Garber AM.

    Ann Intern Med. 1999 May 18;130(10):789-99.PMID: 10366368 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.

    van Den Belt AG, Prins MH, Lensing AW, Castro AA, Clark OA, Atallah AN, Burihan E.

    Cochrane Database Syst Rev. 2000;(2):CD001100. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001100. PMID: 10796593 [PubMed - indexed for MEDLINE]Related articles

    7.

    Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

    van der Heijden JF, Hutten BA, Büller HR, Prins MH.

    Cochrane Database Syst Rev. 2002;(1):CD002001. Review.PMID: 11869618 [PubMed - indexed for MEDLINE]Related articles

    8.

    Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.

    Sandercock PA, Counsell C, Tseng MC.

    Cochrane Database Syst Rev. 2008 Jul 16;(3):CD000119. Review.PMID: 18646059 [PubMed - indexed for MEDLINE]Related articles

    9.

    Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.

    Chande N, McDonald JW, Macdonald JK.

    Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006774. Review.PMID: 18425969 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis.

    Leizorovicz A, Simonneau G, Decousus H, Boissel JP.

    BMJ. 1994 Jul 30;309(6950):299-304.PMID: 8086867 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.

    Sandercock P, Counsell C, Stobbs SL.

    Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000119. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD000119. PMID: 15846600 [PubMed - indexed for MEDLINE]Related articles

    12.

    Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.

    Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Ghali WA, Butcher MS, Brant RF, Bergqvist D, Hamulyák K, Francis CW, Marder VJ, Raskob GE.

    Arch Intern Med. 2001 Sep 10;161(16):1952-60. Review.PMID: 11525697 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.

    Couturaud F, Julian JA, Kearon C.

    Thromb Haemost. 2001 Oct;86(4):980-4.PMID: 11686355 [PubMed - indexed for MEDLINE]Related articles

    14.

    Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants.

    Iorio A, Guercini F, Pini M.

    J Thromb Haemost. 2003 Sep;1(9):1906-13.PMID: 12941030 [PubMed - indexed for MEDLINE]Related articles

    15.

    Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.

    Lensing AW, Prins MH, Davidson BL, Hirsh J.

    Arch Intern Med. 1995 Mar 27;155(6):601-7.PMID: 7887755 [PubMed - indexed for MEDLINE]Related articles

    16.

    Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty.

    Anderson DR, O'Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J.

    Ann Intern Med. 1993 Dec 1;119(11):1105-12.PMID: 8239230 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.

    Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A, Elias D, Grigg A, Musset D, Rodgers GM, Trowbridge AA, Yusen RD, Zawilska K; Enoxaparin Clinical Trial Group.

    Ann Intern Med. 2001 Feb 6;134(3):191-202.PMID: 11177331 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.

    Counsell C, Sandercock P.

    Cochrane Database Syst Rev. 2000;(2):CD000119. Review. Update in: Cochrane Database Syst Rev. 2001;(4):CD000119. PMID: 10796301 [PubMed - indexed for MEDLINE]Related articles

    19.

    A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.

    Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH.

    J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38.PMID: 10901307 [PubMed - indexed for MEDLINE]Related articles

    20.

    Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.

    Magee KD, Sevcik W, Moher D, Rowe BH.

    Cochrane Database Syst Rev. 2003;(1):CD002132. Review.PMID: 12535430 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity